Skip to main content
placeholder image

Effect of a glucagon-like peptide 1 (GLP-1) receptor agonist, liraglutide, on cognition and body weight during antipsychotic treatment

Conference Paper


Abstract


Publication Date


  • 2016

Citation


  • Babic, I., Gorak, A., Hughes, J., Engel, M., Sellers, D., Else, P., . . . Weston-Green, K. (2016). Effect of a glucagon-like peptide 1 (GLP-1) receptor agonist, liraglutide, on cognition and body weight during antipsychotic treatment. In INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY Vol. 19 (pp. 204). SOUTH KOREA, Seoul: OXFORD UNIV PRESS. Retrieved from https://www.webofscience.com/

Number Of Pages


  • 1

Start Page


  • 204

End Page


  • 204

Volume


  • 19

Abstract


Publication Date


  • 2016

Citation


  • Babic, I., Gorak, A., Hughes, J., Engel, M., Sellers, D., Else, P., . . . Weston-Green, K. (2016). Effect of a glucagon-like peptide 1 (GLP-1) receptor agonist, liraglutide, on cognition and body weight during antipsychotic treatment. In INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY Vol. 19 (pp. 204). SOUTH KOREA, Seoul: OXFORD UNIV PRESS. Retrieved from https://www.webofscience.com/

Number Of Pages


  • 1

Start Page


  • 204

End Page


  • 204

Volume


  • 19